Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 231 Records) |
| Query Trace: Neoplasms and ARID1A[original query] |
|---|
| Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations. Cancers 2022 9 14 (17): . Kurzrock Razelle, Aggarwal Charu, Weipert Caroline, Kiedrowski Lesli, Riess Jonathan, Lenz Heinz-Josef, Gandara Dav |
| Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 2022 Sep . Chang Geyun, Li Weihua, Bai Hua, Duan Jianchun, Wang Zhijie, Du Xinyang, Yu Ruofei, Wang Yaxi, Wang Minghao, Zhu Yixiang, Zhang Xue, Li Li, Wan Rui, Wang J |
| Druggable gene alterations in Japanese patients with rare malignancy. Neoplasia (New York, N.Y.) 2022 Sep 33 100834. Ohmoto Akihiro, Hayashi Naomi, Fukada Ippei, Yamazaki Masumi, Yunokawa Mayu, Kasuga Akiyoshi, Shinozaki Eiji, Ueki Arisa, Tonooka Akiko, Takeuchi Kengo, Mori Seiichi, Kiyotani Kazuma, Takahashi Shun |
| "Cancer in ARID1A-Coffin-Siris syndrome: Review and report of a child with hepatoblastoma". European journal of medical genetics 2022 Aug 65 (11): 104600. Cárcamo Benjamín, Masotto Barbara, Baquero-Vaquer Anna, Ceballos-Saenz Delia, Zapata-Aldana Eugen |
| Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens. Urologic oncology 2022 Aug . Papadopoulou Kyriaki, Koliou Georgia-Angeliki, Tsimiliotis Dimitrios, Kotoula Vassiliki, Foukas Periklis, Goussia Anna, Tsiatas Marinos, Visvikis Anastasios, Chatzopoulos Kyriakos, Nifora Martha, Charchanti Antonia, Koumarianou Anna, Christodoulou Christos, Pectasides Dimitrios, Psyrri Amanda, Fostira Florentia, Fountzilas George, Samantas Epaminont |
| Integrated genomic analyses of hepatocellular carcinoma. Hepatology international 2022 12 17 (1): 97-111. Chang Ya-Sian, Tu Siang-Jyun, Chen Hong-Da, Hsu Ming-Hon, Chen Yu-Chia, Chao Dy-San, Chung Chin-Chun, Chou Yu-Pao, Chang Chieh-Min, Lee Ya-Ting, Yen Ju-Chen, Jeng Long-Bin, Chang Jan-Gow |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. Therapeutic advances in medical oncology 2022 12 14 17588359221141761. Lee Jii Bum, Park Hyung Soon, Choi Su Jin, Heo Seong Gu, An Ho Jung, Kim Hye Ryun, Hong Min Hee, Lim Sun Min, Chang Kyle, Quinn Katie, Odegaard Justin, Shim Byoung Yong, Cho Byoung Ch |
| Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors. Clinical genitourinary cancer 2022 12 21 (1): 69-75. Chawla Neal S, Sayegh Nicolas, Tripathi Nishita, Govindarajan Ameish, Zengin Zeynep B, Phillip Errol J, Dizman Nazli, Meza Luis, Muddasani Ramya, Chehrazi-Raffle Alexander, Malhotra Jasnoor, Hsu JoAnn, Agarwal Neeraj, Pal Sumanta K, Tripathi Abhish |
| Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2022 11 32 (12): 1568-1575. van Bommel Majke H D, Pijnenborg Johanna M A, van der Putten Louis J M, Bulten Johan, Snijders Marc P L M, Küsters-Vandevelde Heidi V N, Sweegers Sanne, Vos M Caroline, Ligtenberg Marjolein J L, Eijkelenboom Astrid, de Hullu Joanne A, Reijnen Casp |
| SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases. Cancer cell international 2022 11 22 (1): 347. Li Yue, Yang Xinhua, Zhu Weijie, Xu Yuxia, Ma Jiangjun, He Caiyun, Wang Fa |
| ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
| The mutation and low expression of ARID1A are predictive of a poor prognosis and high immune infiltration in triple-negative breast cancer. Current cancer drug targets 2023 5 . Yuejing Wang, Zhuo Chen, Jing Wu, Hong Yan, Yiran Wang, Jie |
| Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy. Journal of Cancer 2023 5 14 (7): 1216-1222. Jeong Eun Kim, Song Ee Park, Hee Jun Kim, In Gyu Hwa |
| The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
| ARID1A mutations in lung cancer: biology, prognostic role, and therapeutic implications. Trends in molecular medicine 2023 5 . Fukang Jin, Zhiguang Yang, Jingbo Shao, Jianxin Tao, Christoph Reißfelder, Sonja Loges, Lei Zhu, Sebastian Schöl |
| Comprehensive Genome profile testing in head and neck cancer. Auris, nasus, larynx 2023 5 . Masashi Kuroki, Ryota Iinuma, Hiroshi Okuda, Kosuke Terazawa, Hirofumi Shibata, Ken-Ichi Mori, Toshimitsu Ohashi, Akitaka Makiyama, Manabu Futamura, Tatsuhiko Miyazaki, Yukio Horikawa, Takenori Oga |
| Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer. Cancer medicine 2023 4 . Wei Huang, Wenliang Li, Ning Xu, Hui Li, Zihan Zhang, Xiaolong Zhang, Tingting He, Jicheng Yao, Mian Xu, Qingqing He, Lijie Guo, Sen Zha |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
| Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 3 JCO2202144. Sarfaty Michal, Golkaram Mahdi, Funt Samuel A, Al-Ahmadie Hikmat, Kaplan Shannon, Song Fan, Regazzi Ashley, Makarov Vladimir, Kuo Fengshen, Ostrovnaya Irina, Seshan Venkatraman, Zhao Chen, Greenbaum Benjamin, Liu Li, Rosenberg Jonathan E, Chan Timothy |
| Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. Frontiers in immunology 2023 3 14 1090838. Li Mengyuan, Gao Xuejiao, Wang Xiaoshe |
| Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 3 36 (5): 100123. Irshaid Lina, Costigan Danielle C, Dong Fei, Matulonis Ursula A, Nucci Marisa R, Kolin David |
| Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma. Molecular and cellular probes 2023 2 67 101897. Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L |
| Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma. Gene 2023 2 860 147233. Altun Zekiye, Yuan Hongling, Baran Burçin, Akta? Safiye, Sönmez Esra Esmeray, Küçük Can, Olgun N |
| ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2023 2 . Sato Takahiro, Saito Motonobu, Nakajima Shotaro, Saito Katsuharu, Katagata Masanori, Fukai Satoshi, Okayama Hirokazu, Sakamoto Wataru, Saze Zenichiro, Momma Tomoyuki, Mimura Kosaku, Kono Ko |
| ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
| Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer. British journal of cancer 2023 2 . Asami Yuka, Kobayashi Kato Mayumi, Hiranuma Kengo, Matsuda Maiko, Shimada Yoko, Ishikawa Mitsuya, Koyama Takafumi, Komatsu Masaaki, Hamamoto Ryuji, Nagashima Minoru, Terao Yasuhisa, Itakura Atsuo, Kohno Takashi, Sekizawa Akihiko, Matsumoto Koji, Kato Tomoyasu, Shiraishi Kouya, Yoshida Hiros |
| A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy. International journal of molecular sciences 2023 1 24 (1): . Élez Elena, Mulet-Margalef Núria, Sanso Miriam, Ruiz-Pace Fiorella, Mancuso Francesco M, Comas Raquel, Ros Javier, Argilés Guillem, Martini Giulia, Sanz-Garcia Enrique, Baraibar Iosune, Salvà Francesc, Noguerido Alba, Cuadra-Urteaga Jose Luis, Fasani Roberta, Garcia Ariadna, Jimenez Jose, Aguilar Susana, Landolfi Stefania, Hernández-Losa Javier, Braña Irene, Nuciforo Paolo, Dienstmann Rodrigo, Tabernero Josep, Salazar Ramon, Vivancos A |
| Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma. JAMA network open 2023 1 6 (1): e2249674. Brazel Danielle, Kumar Priyanka, Doan Hung, Pan Tianyu, Shen Weining, Gao Ling, Moyers Justin |
| Targeted next-generation sequencing for the detection of cancer-associated somatic mutations in adenomyosis. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2023 1 43 (1): 2161352. Chao Angel, Wu Ren-Chin, Lin Chiao-Yun, Lee Lee-Yu, Tsai Chia-Lung, Lee Yun-Shien, Wang Chin-Ju |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: